-
4 days ago | 
mobihealthnews.com | Jessica Hagen
Omada Health filed an S-1 with the Securities and Exchange Commission (SEC) to go public on Friday, making it the second digital health company to seek an IPO this year. The company did not specify how many shares would be offered or the price range for the proposed offering. It intends to list under the ticker symbol OMDA. got its start in prediabetes management.
-
4 days ago | 
mobihealthnews.com | Jessica Hagen
Omada Health on Friday filed an S-1 with the U.S. Securities and Exchange Commission (SEC) to go public, making it the second digital health company to seek an IPO this year. The company did not specify how many shares would be offered or the price range for the proposed offering. It intends to list under the ticker symbol OMDA. got its start in prediabetes management.
-
1 week ago | 
mobihealthnews.com | Jessica Hagen
Sonde Health announced it is partnering with Saaya Health, a virtual mental health and well-being platform, to extend its combined offerings to large blue-collar workforces. Sonde Health's platform uses its patented voice technology that analyzes short voice samples to detect various health conditions from biomarkers in a person's voice, including respiratory fitness, depression and anxiety.
-
1 week ago | 
mobihealthnews.com | Jessica Hagen
Carta Healthcare has scored $18.25 million in Series B1 financing led by UPMC Enterprises. New investors MemorialCare Innovation Fund, Tampa General Hospital Ventures and Rex Health Ventures (UNC Health's investment fund) participated in the round, alongside existing investors Memorial Hermann Health System, Paramark Ventures, Storm Ventures, Mass General Brigham Ventures, CU Healthcare Innovation Fund and Frist Cressey Ventures.
-
1 week ago | 
mobihealthnews.com | Jessica Hagen
Dexcom is expanding its partnership with health-tracking ring maker Oura to provide Stelo users and ring wearers with metabolic health features, including meal insights and glucose data. Stelo provides individuals 18 and up who do not require insulin with round-the-clock glucose readings and delivers personalized insights into glucose health, offering users actionable information to make informed decisions.
-
1 week ago | 
mobihealthnews.com | Jessica Hagen
Neuralink has successfully implanted its brain-computer interface into a man named Brad Smith, who has ALS and is completely non-verbal, allowing him to communicate now using telepathy. released a video on X about his experience with Neuralink and how it works. The video is narrated using an AI-generated replica of Smith's voice cloned from past recordings, and Smith uses the BCI to control the mouse on his MacBook Pro to perform the narration.
-
1 week ago | 
mobihealthnews.com | Jessica Hagen
Project Stargate, an at least $500 billion investment to build the physical and virtual infrastructure to power AI construction, is considering investment overseas, according to reporting by the Financial Times.
-
2 weeks ago | 
mobihealthnews.com | Jessica Hagen
DarioHealth announced it closed a debt financing facility for up to $50 million by Callodine Group and Rand Capital. The new funding restructures the company's prior credit facility and will be used to advance its B2B2C strategy across pharma partners, self-insured employers and payer organizations. DarioHealth borrowed $32.5 million at closing, and up to $17.5 million is available based on reaching certain revenue achievement thresholds.
-
2 weeks ago | 
mobihealthnews.com | Jessica Hagen
, a workflow-automation platform for pharmacy and healthcare operations, has secured $50 million in Series B funding, bringing its total raise to $76 million. Dahner Corporation cofounder Mitchell Rales and Arena Holdings co-led the round, with participation from Bessemer Venture Partners, TQ Ventures, Notable Capital, Susa/Kivu Ventures, and other investors. The company will use the funds for product development and to speed up its go-to-market efforts.
-
2 weeks ago | 
mobihealthnews.com | Jessica Hagen
Hims & Hers is partnering with Novo Nordisk to allow Americans to access a bundled offering that includes the pharma giant's obesity drug Wegovy and a Hims & Hers membership starting at $599 per month. Hims & Hers members will have direct access to NovoCare Pharmacy, an offering through Novo Nordisk that allows cash-paying individuals without insurance to obtain the medication Wegovy and Hims' offerings, including 24/7 care, nutrition guidance and clinical support.
